BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• BioCapital

  KeifeRx to Present at 2022 BIO CEO & Investor Conference

  KeifeRx, LLC, an emerging clinical-stage biopharmaceutical company specializing in the discovery and development of new treatment options for neurodegenerative diseases, announced that its Chief Executive Officer, Chris Hoyt, will present at the 2022 BIO CEO & Investor Conference.

  February 7, 2022

   · 

  2 min read
• Drug Development

  Hoth Therapeutics Announces Presentation of the HT-ALZ Proof-of-Concept Alzheimer’s Disease Preclinical Data at the 2022 Alzheimer’s Association International Conference

  Dr. Yuede will present the preclinical Alzheimer’s disease mouse model data for exploring HT-ALZ for the treatment of Alzheimer’s disease.

  February 7, 2022

   · 

  4 min read
• Genetown

  Apnimed to Participate in the SVB Leerink Global Healthcare Conference

  Apnimed announced that company management will participate in 1x1 investor meetings at the SVB Leerink Global Healthcare Conference taking place virtually February 14-18, 2022.

  February 7, 2022

   · 

  2 min read
• Business

  MEI Pharma Strengthens Clinical and Quality Expertise with New Key Executive Appointments

  MEI Pharma, Inc. today announced the expansion of its management team with the addition of two experienced industry executives.

  February 7, 2022

   · 

  5 min read
• Biotech Beach

  Endeavor BioMedicines Closes $101M Series B Financing to Advance Clinical-Stage Precision Medicine Pipeline

  Endeavor BioMedicines today announced the completion of a $101 million Series B financing, led by Ally Bridge Group and Avidity Partners.

  February 7, 2022

   · 

  5 min read
• BioForest

  Immusoft to Present at WORLDSymposium™ 2022 Conference

  Immusoft Corporation, a cell therapy company dedicated to improving the lives of patients with rare diseases, announced that it will present at the upcoming WORLDSymposium 2022 Conference, held in San Diego, February 7-11, 2022.

  February 7, 2022

   · 

  1 min read
• Business

  Horizon Therapeutics plc to Release Fourth-Quarter and Full-Year 2021 Financial Results and Host Webcast on March 1, 2022

  Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it will release its fourth-quarter and full-year 2021 financial results on Tuesday, March 1, 2022.

  February 7, 2022

   · 

  1 min read
• Business

  Acasti Pharma Schedules Third Quarter Fiscal 2022 Business Update Conference CallCall to be held on Monday, February 14th at 1:00 PM Eastern Time

  Acasti Pharma Inc. today announced that it will host a conference call at 1:00 PM Eastern Time on Monday, February 14, 2022 to discuss the Company’s corporate progress and other developments, as well as financial results for the fiscal 2022 third quarter ended December 31, 2021.

  February 7, 2022

   · 

  5 min read
• Biotech Bay

  Myovant Sciences to Present at Upcoming Investor Conferences - Feb 07, 2022

  Myovant Sciences, a healthcare company focused on redefining care for women and for men, announced that David Marek, Chief Executive Officer of Myovant Sciences, Inc., and other members of the Myovant executive team will participate in a fireside chat at the following investor conferences:

  February 7, 2022

   · 

  1 min read
• Business

  Coherus BioSciences Appoints Health Care Payer Expert Lee N. Newcomer, M.D., to Board of Directors

  Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS) today announced the appointment of board-certified oncologist and seasoned healthcare executive Lee N. Newcomer, M.D., to its Board of Directors effective February 2, 2022.

  February 7, 2022

   · 

  6 min read